Genetic Factors in Inherited Neuropathies

Introduction -

Disorders of the neurological system known as neuropathies impair normal nerve function, both motor and sensory. They impact peripheral nerves or those that extend beyond the brain and spinal cord. Genetically, hereditary neuropathies are inherited from parents to children. They occasionally go by the name of hereditary neuropathies. Additionally, neuropathies might be acquired or non-hereditary. Other disorders like diabetes, thyroid disease, or alcohol use disorder can lead to acquired neuropathies. The cause of idiopathic neuropathies is unknown.

Do Genetic Factors Play a Role in Inherited Neuropathies?

Genetic factors play a crucial role in inherited neuropathies. These neuropathies are caused by mutations in specific genes that affect the structure and function of the peripheral nerves. Different types of inherited neuropathies are associated with various genetic mutations, each impacting nerve function through distinct mechanisms. Understanding these genetic factors is essential for accurate diagnosis, management, and the development of targeted therapies.

For example, the most prevalent hereditary neuropathy, Charcot-Marie-Tooth disease, is caused by mutations in genes such as PMP22, MPZ, and MFN2, which result in abnormalities in the formation of myelin and axonal transport. Genes like NTRK1 and SPTLC1 are mutated in hereditary sensory and autonomic neuropathies (HSAN), impacting lipid metabolism and sensory neuron survival. Furthermore, mutations affecting motor neuron function and protein stability in genes such as HSPB1 and BSCL2 have been associated with hereditary motor neuropathies (HMN) and distal hereditary motor neuropathies (dHMN).

What Are the Classifications of Inherited Neuropathies?

Based on their clinical and genetic features, inherited neuropathies are generally divided into multiple categories. The most typical kinds consist of:

1. Charcot-Marie-Tooth Disease (CMT): Affected individuals comprise one in 2,500 cases of this most common genetic neuropathy. Based on inheritance patterns and genetic alterations, it is further separated into subtypes:

• CMT1: Produced by mutations in PMP22 and MPZ, two genes encoding myelin proteins.

• CMT2: Caused by mutations in genes like MFN2 and GJB1 linked to axonal function.

• CMTX: Associated with X chromosomal GJB1 gene mutations.

1. Hereditary Sensory and Autonomic Neuropathies (HSAN): The primary nerves affected by hereditary sensory and autonomic neuropathies (HSAN) are the sensory and autonomic nerves. Numerous genes, including SPTLC1 and NTRK1, have been linked to mutations.

2. Hereditary Motor Neuropathies (HMN): HSPB1 and GARS gene mutations are linked to HMN, characterized by progressive muscle weakening and atrophy.

3. Distal Hereditary Motor Neuropathies (dHMN): DYNC1H1 and BSCL2 gene mutations are associated with dHMN, a condition similar to HMN but mostly affecting distal muscles.

What Are the Genetic Mutations and Pathophysiological Mechanisms Involved in Inherited Neuropathies?

Normal nerve function is disrupted by the genetic mutations that cause hereditary neuropathies through a variety of mechanisms:

• Myelin Formation and Maintenance: In CMT1, aberrant myelin sheath formation results from mutations in the PMP22 gene, compromising nerve transmission. Likewise, mutations in MPZ impact myelin protein zero, which is crucial for maintaining myelin integrity.

• Axonal Transport and Mitochondrial Function: In CMT2, energy generation and axonal transport are impacted by mutations in MFN2, which impair mitochondrial fusion. Axonal degeneration and loss of nerve function are the outcomes of this.

• Ion Channel Function and Neuronal Excitability: Mutations in GJB1 (CMTX) impact the connexin 32 protein, which is essential for gap junctions in myelinating Schwann cells. This disturbance results in impaired neuronal signaling and ion flow.

• Lipid Metabolism and Neuronal Survival: In HSAN, sphingolipid metabolism (network of interconnected metabolic pathways) is disrupted by mutations in SPTLC1, which results in a toxic build-up of intermediate chemicals that damage sensory neurons.

• Protein Aggregation and Stress Response: Motor neuron degeneration is brought on by HMN-related mutations in HSPB1 and GARS, which disrupt stress response and protein folding processes.

What Are the Risk Factors for Inherited Neuropathies?

Having a parent who has the disease or possesses particular gene mutations is the biggest risk factor for hereditary neuropathy. As an example, there is a 50 percent probability that a parent with CMT disease will pass the illness on to their offspring. On the other hand, a person may acquire CMT at random. Researchers hypothesize unknown genes may contribute to inherited neuropathies and the known gene variants linked to the illness. Specific risk factors may exacerbate symptoms in individuals with hereditary neuropathy, according to specific research. According to investigations, the following are risk factors for symptoms to get worse:

1. Hypothyroidism.

2. Obesity.

3. Diabetes.

How Are Inherited Neuropathies Diagnosed, and What Role Does Genetic Testing Play?

Genetic tests, electrophysiological investigations, and clinical assessment are all used to diagnose hereditary neuropathies. Specifically, genetic testing is useful for:

• Identifying Specific Mutations: Determining the precise genetic mutation helps verify the diagnosis and comprehend the pathophysiology of the illness.

• Family Screening: Genetic testing yields information for genetic counseling and assists in identifying family members who may be at risk.

• Personalized Medicine: Knowledge of the genetic causes of neuropathy can inform individualized treatment plans and even clinical trial involvement.

What Therapeutic Approaches Are Available for Managing Inherited Neuropathies?

Although there is no treatment for inherited neuropathies, there are ways to control symptoms and delay the course of the condition:

• Pharmacological Treatments: Drugs such as Pregabalin and Gabapentin can reduce neuropathic pain. Ongoing research aims to create treatments based on individual genes, such as RNA-based therapeutics and gene editing.

• Physical Therapy and Rehabilitation: Regular exercise, physical therapy, and occupational therapy are recommended to preserve muscle strength and enhance mobility.

• Orthopedic Treatments: To improve function, skeletal abnormalities can be treated with orthotic devices and surgical treatments.

• Supportive Care: A complete approach to treating people with hereditary neuropathies must include both patient education and psychological support.

Conclusion-

Various diseases with various genetic foundations are included in inherited neuropathies. Genetic research has made tremendous strides in our knowledge of these disorders, opening the door to more precise diagnoses and focused treatment approaches. It is possible to improve the quality of life for those who suffer from inherited neuropathies and find effective treatments by conducting further studies into the molecular mechanisms and genetic variables underlying these conditions.